With the addition of Japan's largest Web3 gaming company behind TOKYO BEAST, Immutable cements its dominance in Asia's Web3 gaming market. Immutable, the leading Web3 gaming platform, today announced a partnership with Japan's No.1 mobile gaming developer, to bring TOKYO BEAST, a highly anticipated blockchain battler to Web3. This partnership marks Immutable's third unicorn developer […]
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg So what: If you purchased Regeneron securities during the Class Period you
Pomerantz LLP is investigating claims on behalf of investors of Skyworks Solutions, Inc. (“Skyworks” or the “Company”) (NASDAQ: SWKS).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Skyworks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of Eldorado Gold Corporation (“Eldorado” or the “Company”) (NYSE: EGO).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Eldorado and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp (“GeneDx” or the “Company”) (NASDAQ: WGS).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether GeneDx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Canopy Growth Corporation and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Pomerantz LLP is investigating claims on behalf of investors of Pagaya Technologies Ltd (“Pagaya” or the “Company”) (NASDAQ: PGY).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Pagaya and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (“Pliant” or the “Company”) (NASDAQ: PLRX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Pliant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here
Pomerantz LLP is investigating claims on behalf of investors of NAPCO Security Technologies, Inc (“NAPCO” or the “Company”) (NASDAQ: NSSC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether NAPCO and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeutics, Inc (“Voyager” or the “Company”) (NASDAQ: VYGR).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Voyager and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here